Cannabis M&A Heats Up
By Sheeba M. | June 10, 2026 Cannabis M&A Heats Up TL;DR: Mid-market cannabis operators are accelerating M&A ahead of potential federal rescheduling. Sources SEC EDGAR
Cannabis Cultivation Oversupply: Which MSOs Will Survive the Squeeze?
By Sheeba M. | June 10, 2026 Cannabis Cultivation Oversupply: Which MSOs Will Survive? TL;DR: Oversupply pushing prices down 30-40% squeezes margins. Winners have best genetics and retail control. Cultivation market faces boom-bust with significant oversupply across regulated markets. Wholesale prices compress while not all growers survive. The Oversupply Reality California, Colorado, Oregon show prices […]
Federal Cannabis Rescheduling: What It Means for MSO Valuations
By Sheeba M. | June 10, 2026 Federal Cannabis Rescheduling: What It Means for MSO Valuations TL;DR: Federal rescheduling could unlock billions in institutional capital for MSOs through reduced banking friction and tax relief. For years, multi-state operators have operated in a legal gray area. Recent Senate movements and bipartisan support suggest meaningful policy inflection […]
Test
Test
Section 280E Relief: What Cannabis Operators Need to Know Before July
By Sheeba M. | June 9, 2026 Section 280E Relief: What Cannabis Operators Need to Know Before July TL;DR: Draft legislation to repeal Section 280E is gaining momentum. Cannabis operators should begin preparing tax strategies now for potential relief. This could add 15-20% to bottom-line profitability for major MSOs. Cannabis businesses operating under Section 280E […]
Cannabis REITs Show Resilience as Federal Legalization Debate Heats Up
By Sheeba M. | June 9, 2026 Cannabis REITs Show Resilience as Federal Legalization Debate Heats Up TL;DR: Major cannabis REITs like Innovative Industrial Properties (IIPR) are gaining investor confidence ahead of potential federal rescheduling. Institutional capital is quietly positioning for legislative wins, creating early-stage buying opportunities. The cannabis real estate sector is entering a […]
Lab Testing Automation Drives Cannabis Compliance Costs Down 25%
By Sheeba M. | June 09, 2026 Lab Testing Automation Drives Cannabis Compliance Costs Down 25% TL;DR: Major cannabis operators are slashing lab testing expenses through automation adoption, improving gross margins by 200+ basis points. One of the most underappreciated tailwinds in the cannabis industry is the dramatic reduction in lab testing and compliance costs. […]
Cannabis ETF Rotation Signals Institutional Capital Inflow
By Sheeba M. | June 09, 2026 Cannabis ETF Rotation Signals Institutional Capital Inflow TL;DR: Institutional capital rotating into cannabis ETFs as regulatory headwinds ease and earnings improve. The cannabis industry continues its march toward legitimacy, with institutional investors taking notice. Recent ETF data reveals a surge in trading volume, signaling renewed confidence among sophisticated […]
Cannabis ETF Rotation
By Sheeba M. | June 09, 2026 Cannabis ETF Rotation
Federal Rescheduling Unlocks Cannabis Supply Chain Investment
By Sheeba M. | June 9, 2026 Federal Rescheduling Unlocks Cannabis Supply Chain Investment TL;DR: Post-rescheduling, traditional supply chain companies are entering cannabis distribution. This unlocks $2B+ in logistics infrastructure upgrades. XPO Logistics (XPO) and cannabis ancillary plays are the beneficiaries of federal regulatory clarity. The federal rescheduling of cannabis to Schedule III in 2024-2025 […]